Sidekick Health has announced the acquisition of PINK!, a pioneering digital health company specializing in cancer support and women’s health. This acquisition enhances Sidekick Health’s portfolio and strengthens its position in the digital therapeutics market.
PINK! operates a physician-led online platform for breast cancer patients, offering digital therapeutics. The health-tech startup from Hamburg developed PINK! Coach, the first and only breast cancer app permanently approved as a DiGA (app on prescription). This app serves as a digital companion for breast cancer patients, providing scientifically-based medical information and guidance. Founded in 2020, PINK! employs 27 staff members and collaborates with many medical and scientific experts.
Sidekick Health is a digital therapeutics company that helps people prevent and manage chronic diseases. Sidekick provides a wide range of digital health programs, including oncology, cardiovascular, metabolic, inflammatory and other chronic conditions. Sidekick works with health insurers and pharmaceutical companies to improve patient outcomes, drive clinical efficiency and lower the cost of care. The company currently operates in multiple global markets and across the United States, including patients in all insurance classes (Medicare, Medicaid and Commercial).
This acquisition follows Sidekick’s successful acquisition of aidhere in October 2023, which marked Sidekick’s entry into the prescription digital therapeutics market with the addition of aidhere’s zanadio app for obesity management. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the 110th eHealth transaction of 2024, and the 19th in the telehealth specialty.
